ENSTILAR FDA approval date

The FDA approved ENSTILAR on 16 Oct 2015.

FDA approval date
16 Oct 2015

Drug identity has not yet been verified against registry records

Also recorded as BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-10-16DayENSTILARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207589", "applicant_as_listed_by_fda": "LEO PHARMA AS", "brand_names": ["ENSTILAR"], "active_ingredients": ["BETAMETHASONE DIPROPIONATE", "CALCIPOTRIENE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151016", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026